Development and Systematic Evaluation of a Low-Irritation PFD-AIS Formulation for Pulmonary-Targeted Therapy.

Pharmaceuticals (Basel) · 2026 · PMC12942897 · PMID 41754739

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Figure 2 A shows a decreasing trend in delivery rate with increasing sodium chloride concentration, with rates of 2.84, 2.31, and 2.08 mg/min.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.